News | Neuro Imaging | February 06, 2017

Astronauts' Brains Change Shape During Spaceflight

MRI exams reveal structural changes in gray matter based on length of time spent in space

astronaut brain changes, spaceflight, MRI, Nature Microgravity

Image courtesy of NASA

February 6, 2017 — Magnetic resonance imaging (MRI) exams before and after space missions reveal that astronauts' brains compress and expand during spaceflight, according to a University of Michigan study.

The findings could have applications for treating other health conditions that affect brain function, said principal investigator Rachael Seidler, U-M professor of kinesiology and psychology.

The study, believed to be the first to examine structural changes that take place in astronauts' brains during spaceflight, found that the volume of gray matter increased or decreased, and the extent of the alteration depended on the length of time spent in space.

Seidler and colleagues examined structural MRIs in 12 astronauts who spent two weeks as shuttle crew members, and 14 who spent six months on the International Space Station. All experienced increases and decreases in gray matter in different parts of the brain, with more pronounced changes the longer the astronauts spent in space.

"We found large regions of gray matter volume decreases, which could be related to redistribution of cerebrospinal fluid in space," Seidler said. "Gravity is not available to pull fluids down in the body, resulting in so-called puffy face in space. This may result in a shift of brain position or compression."

The researchers also found increases in gray matter volume in regions that control leg movement and process sensory information from legs, which may reflect changes related to the brain learning how to move in microgravity. These changes were greater in space station astronauts because their brains were learning and adapting 24/7.

"It's interesting because even if you love something you won't practice more than an hour a day," Seidler said.

But the brain changes researchers observed were equivalent to someone practicing a new skill round-the-clock.

"In space, it's an extreme example of neuroplasticity in the brain because you're in a microgravity environment 24 hours a day," Seidler said.

Though they have not pinpointed the exact nature of the changes yet, the findings may lead to new ways of thinking about certain health conditions — for example, people on long-duration bed rest or people who have normal pressure hydrocephalus, a condition in which cerebrospinal spinal fluid accumulates in ventricles in the brain and causes pressure.

Seidler said the brain changes could reflect new connections between neurons, and she's leading another long-term study that will help determine the repercussions on cognition and physical performance, as well as how long the brain changes last. For example, even after balance returns, the brain might still recruit different pathways to compensate for the structural brain changes caused by spaceflight.

"The behavior may return to normal, but the way the brain controls the behavior may change," she said.

These results largely parallel findings from a long-term bed rest study that Seidler is leading, in which volunteers spent up to three months in downward tilted position, and brains shifted up.

The research is supported by a grant from NASA.

The study, "Brain structural plasticity with spaceflight," appeared in the journal Nature Microgravity.

For more information: www.nature.com/npjmgrav

References

Kopplemans, V., Bloomberg, J.J., Mulavara, A.P., Seidler, R.D. "Brain structural plasticity with spaceflight," Nature Microgravity. Published online Dec. 19, 2016. doi:10.1038/s41526-016-0001-9

Related Content

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...
Medic Vision Wins Japanese PMDA Clearance for iQMR Image Reconstruction Solution
News | Magnetic Resonance Imaging (MRI) | July 05, 2019
Medic Vision Imaging Solutions announced that its 3-D iterative image reconstruction technology for shortening magnetic...
Bay Labs Announces New Echocardiography Guidance Software Data at ASE 2019 Scientific Sessions
News | Cardiovascular Ultrasound | June 20, 2019
Bay Labs announced that new data on the company’s first-of-its-kind deep learning investigational guidance software...
Third FDA Clearance Announced for Zebra-Med's AI Solution for Brain Bleed Alerts
Technology | Artificial Intelligence | June 19, 2019
Zebra Medical Vision announced it has received its third U.S. Food and Drug Administration (FDA) 510(k) clearance for...